01. The principle
The AI is one component, not the authority
AccuRXy does not simply ask a language model to generate a scenario and hope for the best. The reference sources are not cited after the fact; they are retrieved first and used to guide and constrain what the model produces.
The AI model is one component of AccuRXy, not the authority.
AccuRXy owns the evidence, governs what is authoritative, determines the jurisdiction and maintains the academic audit trail. The AI generates content within a governed framework; it does not determine what is clinically correct.
Seven layers of AI governance
User experience
Scenario Design Lab, AI Tutor, Scenario Library, Academic Review
Scenario orchestration engine
Interprets requests, retrieves evidence, controls generation, saves results
Evidence retrieval layer
Search and filter, ranking and matching, jurisdiction filtering
Model gateway
Provider-neutral interface to GPT, Claude and Gemini
Knowledge and clinical rules
Documents, medicines data, protocols, taxonomies, rules
Validation and academic governance
Citations, consistency checks, review workflow, audit trail
Integration interfaces
Internal API, Partner API, FHIR where useful, MCP gateway
02. The governed workflow
How a scenario is built
Every request begins with a structured scenario specification rather than a free-text prompt, and passes through the same orchestration engine from evidence retrieval to academic review.
The structured specification collects
The engine never hands the specification directly to an AI model. It follows a governed workflow.
- 01
Receive scenario specification
The structured parameters define what kind of scenario is needed.
- 02
Determine required evidence categories
The engine identifies which source documents, medicine records and clinical rules are relevant.
- 03
Retrieve approved evidence
The Evidence Retrieval Layer fetches jurisdiction-appropriate, current, approved materials.
- 04
Construct an evidence pack
Relevant passages, structured medicine records and clinical rules are assembled into a package.
- 05
Generate scenario skeleton
The AI model produces a structured scenario using the evidence pack as its source material.
- 06
Generate dialogue and assessment content
Full content is produced within the constraints of the evidence pack.
- 07
Run medicine and consistency checks
Generated content is validated against structured medication data and internal consistency rules.
- 08
Attach citations
Every material clinical claim is mapped to a specific passage in a specific approved document.
- 09
Calculate validation status
Automated checks produce an assurance summary before the scenario enters academic review.
- 10
Save as draft for academic review
The scenario enters a review and approval workflow before publication or assessment use.
03. The knowledge platform
Three forms of evidence, one version-controlled platform
AccuRXy is not a generic document store. Each form of knowledge serves a different function in scenario generation, and each source carries the metadata that makes academic traceability possible.
Source documents
Original authoritative documents: clinical guidelines, regulatory guidance, SmPCs and authorised product information, practice standards, SOPs, peer-reviewed literature, university-approved educational material and medication-safety reports. Stored in encrypted object storage.
Structured medicines and clinical data
Active ingredients, strengths, formulations, routes, licensed indications, contraindications, interactions, monitoring requirements, controlled drug status and jurisdiction, held as structured records. A language model should not be relied upon as the definitive source of whether a strength, formulation or interaction exists.
AccuRXy proprietary knowledge
The commercially defensible layer that develops over time: medication-error taxonomy and error pattern library, scenario templates and difficulty models, learning-objective mappings and scoring rubrics, common misconceptions and distractor rules, clinical reasoning pathways, validated exemplars and data on which scenarios learners find difficult.
Every source document carries structured metadata
Source ID and title
Publisher and document type
Jurisdiction and clinical topic
Publication, effective and review dates
Version, superseded status, approval status
Licence, academic owner and original URL
This metadata is what creates academic traceability. AccuRXy can demonstrate not just that a scenario was informed by a source, but which version of that source was approved and current on the date the scenario was generated.
04. Retrieval
Evidence first: retrieval-augmented generation
AccuRXy prepares the evidence pack before the model is called. Jurisdiction and version are explicit filters, and the model works only within the evidence it has been given.
AccuRXy does not ask an AI model a free-text question. The evidence comes first: the retrieval service selects approved, jurisdiction-appropriate material before the model is involved at all.
Semantic search for conceptually relevant passages
Keyword search for exact terminology and medicine names
Metadata filters: jurisdiction, approval status, effective date, learner level
Source-authority weighting
Relevance reranking
Jurisdiction and version control are explicit filters, not afterthoughts. An Irish scenario will not silently return a superseded UK or US protocol because it is semantically similar.
The evidence pack
A curated collection of relevant source passages, structured medicine records, applicable clinical rules and required learning outcomes, each carrying its source identifiers and version details. The pack is supplied to the model, not generated by it: the model completes a defined output schema with sections for patient profile, scenario steps, decision points, correct actions, distractors, feedback and source claims.
Provider neutral by design
AccuRXy can use OpenAI, Anthropic (Claude) or Google Gemini through the same model gateway. The evidence pack is prepared by AccuRXy before the model is called, so whichever model is selected works from the same governed evidence. The academic standard is consistent regardless of AI provider.
05. Validation
From mostly accurate to demonstrably governed
Generating a scenario is not the end of the process. Six layers of validation sit between a generated draft and a scenario approved for teaching or assessment.
Schema validation
Every scenario must contain all mandatory sections: learning objective, patient information, clinical cues, decision points, correct answer, explanation and references. A scenario missing any mandatory section cannot progress.
Evidence-entailment validation
For every important clinical claim, AccuRXy checks whether the cited source passage actually supports that claim. This is claim-level citation mapping, not a bibliography appended at the end.
Structured-data validation
Generated content is checked against the medicines database: is the product real, does the stated strength exist, is the route valid, is the dose plausible, does the named interaction exist, is the patient age compatible.
Internal-consistency validation
The intended error must appear in the scenario, the correct answer must genuinely resolve it, the explanation must agree with the answer, the medicine list must stay consistent throughout, and no distractor may be accidentally clinically correct.
Second-pass model review
A second AI model can act as a critic, evaluating the draft against the evidence pack before human review. It improves quality but is not treated as the final academic authority.
Human academic review
For assessed teaching or formal CPD, final approval rests with a qualified academic or relevant professional reviewer, moving through a defined status workflow.
Claim-level citation mapping, an example
| Clinical claim | Source | Supporting passage | Result |
|---|---|---|---|
| Proposed dose is potentially unsafe | Source 104 | Section 4.2 | Supported |
| Drug interaction is clinically relevant | Source 221 | Interaction table | Supported |
| Pharmacist should contact the prescriber | SOP 018 | Escalation section | Supported |
Review status workflow
01 AI Draft
Generated and awaiting automated validation
02 Automatically Validated
Passed all automated checks
03 Academic Review Required
Flagged for human expert review
04 Faculty Approved
Reviewed and approved by a named academic
05 Published
Available for use in teaching or assessment
06 Review Due / Superseded
Source material updated, re-review required
06. Transparency
What academics and partners can see
Every scenario carries an Evidence and Assurance panel, and every generation saves an immutable evidence pack that records exactly how the content was produced.
Evidence and Assurance panel
Governance made visible inside every scenario
- Scenario assurance status
- Faculty Approved
- Evidence retrieval
- 8 approved sources
- Jurisdiction
- Ireland
- Sources current at generation
- Yes
- Medication records validated
- Passed
- Clinical-rule checks
- 12 / 12 passed
- Citation support
- 17 / 18 claims supported
- Academic reviewer
- Named faculty member
- Review date
- 25 June 2026
- Scenario version
- 2.1
- Model used
- Provider, model name and version recorded
- Evidence-pack version
- EP-8462
An academic reviewing a decision point can click through to the specific source title, supporting passage, section or page reference, source version, date accessed and a link to the original where permitted.
The immutable evidence pack, saved at the moment of generation
Scenario specification and prompt-template version
Retrieved source IDs and passages
Structured medicine records used
Clinical rules applied
Model provider, model name and version
Generation settings and raw structured response
Validation results
Human edits
Reviewer identity and approval decision
Timestamp
If a clinical guideline is updated six months after a scenario was generated, AccuRXy can demonstrate which version was approved and current on that date. Old scenarios are never silently regenerated using newer sources; they are marked for review.
Technical data stores
| Store | Purpose |
|---|---|
| PostgreSQL with pgvector | Users, organisations, scenarios, versions, sources and metadata, review records, citations, validation results, clinical rules, model run logs, audit trail |
| Object storage (e.g. AWS S3) | Original PDFs, guideline documents, tables, images, evidence file imports, generated exports |
| Search index / vector store | Document chunks, embeddings, keyword search and hybrid retrieval. pgvector for MVP, OpenSearch or Elasticsearch at scale |
| Rules service | Application code and database-driven clinical validation rules. No complex enterprise rules engine required for MVP |
07. Evidence source inventory
Seven pillars of source material
A granular inventory of the reference sources, guidelines, legislation and clinical data from which AccuRXy constructs jurisdiction-appropriate evidence packs for the Irish jurisdiction.
Structured data
Queryable database records: medicines, rules, taxonomy
Document chunks
Indexed text passages for semantic and keyword retrieval
Linked / referenced
External source, licensing or access arrangement needed
Regulatory: Medicines Authorisation and Product Information
The anchor of the evidence pack. Every Irish pharmacy scenario involving a specific medicine must be grounded in the authorised product information for that medicine as licensed in Ireland by the HPRA or the EMA. This pillar is what gives AccuRXy jurisdiction specificity: it uses Irish product information, not UK or US sources.
| Source | Held as | Role in the evidence pack |
|---|---|---|
| medicines.ie | Document chunks | The official Irish SmPC and PIL database, continuously updated by pharmaceutical companies under HPRA/EMA approval. Covers all brands and generics licensed and marketed in Ireland. The primary Irish jurisdiction product information source, not the UK EMC and not the BNF. |
| HPRA Find a Medicine database | Document chunks | The statutory HPRA listing of every human medicine assessed and licensed for the Irish market: SmPC, PIL, Public Assessment Report and educational materials such as pregnancy prevention programmes for isotretinoin, valproate and clozapine. |
| EMA product database (centrally authorised products) | Document chunks | Authoritative for biologicals, orphan drugs, oncologics and other centrally authorised products. EMA SmPCs are valid across all EU member states including Ireland, used where a product is not separately authorised by HPRA. |
| HPRA Drug Safety Newsletter | Document chunks | Regular pharmacovigilance updates specific to Ireland: prescribing changes, new safety warnings and direct healthcare professional communications. Dynamic content requiring versioned ingestion. |
| HPRA Interchangeable Medicines List | Structured data | The statutory list of generic substitution permitted products, directly relevant to dispensing error scenarios involving generic switching or brand-change queries. |
| HPRA Medicines Shortage Notifications | Structured data | Live list of current and recently resolved shortages, relevant to dispensing decision scenarios where the prescribed product is unavailable. |
| HPRA Educational Materials (EdMs) | Document chunks | Risk minimisation materials for high-risk medicines: isotretinoin, valproate, clozapine, thalidomide and methotrexate. Mandatory dispensing requirements and rich material for high-stakes scenario design. |
Licensing note: medicines.ie is operated commercially and content licensing for AI retrieval will require a formal agreement. This is the most critical commercial relationship to establish for Irish jurisdiction accuracy.
Regulatory: Irish Pharmacy Legislation
Irish pharmacy law is the framework within which every scenario must operate. Most generic AI tools have no structured awareness of Irish pharmacy legislation as a coherent body of law. This pillar allows AccuRXy to generate scenarios that are not only clinically plausible but legally accurate for Ireland.
Primary legislation
| Source | Held as | Role in the evidence pack |
|---|---|---|
| Pharmacy Act 2007 (as amended) | Document chunks | The principal Act governing pharmacy regulation in Ireland: PSI functions, registration of pharmacists and pharmacies, fitness to practise. As amended by the Regulated Professions (Health and Social Care) (Amendment) Act 2020. |
| Misuse of Drugs Acts 1977 to 2016 (consolidated) | Document chunks | The primary legislation controlling scheduled substances in Ireland. Underpins all controlled drug scenarios: opioids, benzodiazepines, stimulants and cannabis-based medicines. |
| Misuse of Drugs Regulations 2017, S.I. No. 173 | Document chunks | The operational statutory instrument for controlled drugs: schedules 2 to 5, prescribing requirements, record-keeping obligations, CD safe storage and destruction. The most clinically scenario-relevant piece of controlled drug law. |
| Medicinal Products (Prescription and Control of Supply) Regulations 2003, S.I. No. 540 | Document chunks | The primary framework for prescription-only medicines: prescription requirements, emergency supply, pharmacist and nurse prescribing. Scenarios on prescription validity or emergency supply draw directly from this. |
| Regulation of Retail Pharmacy Businesses Regulations 2008, S.I. No. 488 | Document chunks | Minimum standards for pharmacy premises, record keeping and operations. Relevant to premises compliance, duty pharmacist requirements and SOP scenarios. |
| Medicinal Products (Control of Placing on the Market) Regulations 2007 | Document chunks | Governs market authorisation and supply chain integrity, relevant to falsified medicines and product recall scenarios. |
PSI subordinate rules
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI (Retail Pharmacy Businesses) (Registration) Rules 2008 | Document chunks | Operational rules for pharmacy registration and ongoing compliance, referenced in premises and record-keeping scenarios. |
| PSI (Education and Training) (Integrated Course) Rules 2014 | Document chunks | The legal basis for the PSI five-yearly accreditation cycle of MPharm programmes, relevant to academic governance scenarios. |
Professional Standards: PSI Guidelines and Guidance
PSI guidelines sit between statute and professional expectation. They define what good practice looks like in specific situations and are the primary source for scenario-relevant clinical decision-making rules: what should a pharmacist do, when, and why.
Dispensing, supply and records
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI Guidelines on the Keeping of Records in Respect of Medicinal Products (Version 4, March 2024) | Document chunks | Current version. Daily dispensing record, controlled drug registers, Schedule 2 to 4 requirements and computerised record systems. Specific enough to generate prescription-record error scenarios at clause level. |
| PSI Guidelines on the Storage of Medicinal Products within a Retail Pharmacy Business | Document chunks | Cold chain, fridge management and CD safe storage, relevant to temperature-excursion and storage-error scenarios. |
| PSI Guidelines on the Disposal of Medicinal Products within a Retail Pharmacy Business | Document chunks | Patient-returned medicines, waste and controlled drug destruction, relevant to safe disposal and regulatory compliance scenarios. |
| PSI Guidelines for Retail Pharmacy Businesses: Premises Requirements | Document chunks | Consultation room, dispensary layout and access requirements, used to contextualise community pharmacy scenarios. |
Controlled drugs
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI/Medical Council Joint Guidance on Safe Prescribing and Dispensing of Controlled Drugs (updated 2024) | Document chunks | Schedules 2, 3 and 4 Part 1. Opioid prescribing patterns, methadone and buprenorphine supply, requisition formats, forgery recognition and escalation pathways. One of the most scenario-rich documents in the Irish pharmacy literature. |
| PSI Guidance for Pharmacists on the Safe Supply of Methadone and Buprenorphine for Opioid Substitution | Document chunks | Operational guidance for OST dispensing: instalment dispensing, supervised consumption and emergency supply. High-stakes, high-frequency scenario territory. |
Vaccination and clinical services
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI Guidance on the Provision of Vaccination Services by Pharmacists in Retail Pharmacy Businesses | Document chunks | The framework for pharmacist-led vaccination: consent, anaphylaxis management and record keeping. Updated annually for each vaccination season. |
| PSI Guidance on the Provision of an Influenza Vaccination Service for Children Aged 6 Months and Older | Document chunks | Paediatric-specific guidance, relevant to dose selection, parental consent and age-band error scenarios. |
| PSI Guidance on Non-Prescription Medicinal Products Containing Codeine | Document chunks | A common community pharmacy consultation scenario: appropriate supply criteria, patient questioning and misuse risk management. |
| PSI Guidance on the Administration of Injectable Medicines by Pharmacists | Document chunks | Relevant to clinical services training scenarios involving injectable administration by pharmacists. |
Patient safety and error learning
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI Learning from Inquiries (Professional Conduct Committee case summaries) | Document chunks | Anonymised real Irish disciplinary proceedings involving dispensing errors, wrong patient, wrong dose and controlled drug irregularities. Arguably the most valuable source in the entire inventory for authentic Irish medication error scenarios. |
| PSI Inspection Findings Overview | Document chunks | Patterns emerging from actual PSI pharmacy inspections, giving scenario contexts grounded in real compliance failures in Irish pharmacies. |
| PSI Practice Updates | Document chunks | Rolling publication series covering dispensing and medication errors, patient safety, recalls, falsified medicines and practice information. Requires regular re-ingestion. |
Academic reviewer note: PSI Learning from Inquiries cases are publicly available, but their use in AI-generated educational scenarios may benefit from PSI engagement or ethical framing, even though all cases are anonymised.
Medicines Information: Clinical Reference Sources
These are the sources Irish pharmacists and pharmacy students use at the point of care. Including them ensures AccuRXy generates scenarios using the same reference frameworks that students are trained on and assessed against.
| Source | Held as | Role in the evidence pack |
|---|---|---|
| Irish Medicines Formulary (IMF) | Structured data and document chunks | The only Ireland-specific, fully independent clinical medicines reference. Covers all licensed and marketed products: indications, dosages, interactions, contraindications, side effects, HSE reimbursement status and HPRA interchangeability. Updated twice yearly. AccuRXy should pursue a licensing agreement with IMF Media. |
| MIMS Ireland | Linked / referenced | A prescribing and drug directory reference used by Irish GPs, relevant to the prescriber-side information environment that pharmacy students must navigate. |
| National Medicines Information Centre (NMIC) bulletins | Document chunks | Based at St James's Hospital Dublin. Evidence-based drug information bulletins and responses to medicines information queries, giving Ireland-specific context on interactions, dosing in special populations and therapeutic alternatives. |
| HSE Medicines Management Programme guidance | Document chunks | Preferred medicines lists, best-value biologicals and managed access protocols for high-cost medicines. Directly relevant to reimbursement and High Tech dispensing scenarios. |
| HSE Primary Care Reimbursement Service (PCRS) schemes | Structured data | GMS, DPS, LTI, High Tech Arrangement and Hardship schemes. Essential for scenarios involving reimbursement eligibility, scheme switching or patient payment queries. |
| HSE National Clinical Guidelines (NCEC series) | Document chunks | Numbered, evidence-based, HSE-approved guidelines, providing clinical context for monitoring-heavy scenarios such as anticoagulation, diabetes and asthma. |
Education and Competency Framework
This pillar is what makes AccuRXy academically credible to pharmacy faculty. Every scenario's learning objectives can be mapped to the national competency framework and institutional curricula. This is the answer to how the platform knows a scenario is appropriate for a Year 3 student at a given school.
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI Core Competency Framework for Pharmacists (Version 2, December 2022, updated September 2023) | Structured data | The definitive competency map for Irish pharmacy. Four domains, Personal, Professional, Organisation and Management Skills and Pharmacy Care, plus Public Health. Embedded throughout MPharm programmes at TCD, UCC and RCSI, and every scenario maps its objectives to specific competencies. |
| PSI MPharm Accreditation Standards | Document chunks | The standards against which MPharm programmes are evaluated, defining what a PSI-accredited pharmacy graduate must demonstrate. Used to calibrate scenario difficulty and coverage. |
| PSI Accreditation Report: TCD (2025) | Document chunks | The most recent TCD accreditation report, with observations on learning outcome alignment, OSCE design and clinical placement assessment. |
| PSI Accreditation Reports: UCC and RCSI | Document chunks | Equivalent reports for UCC and RCSI, essential for institution-specific scenario calibration. |
| APPEL (Affiliation for Pharmacy Practice Experiential Learning) placement frameworks | Document chunks | National body managing practice placements for TCD, UCC and RCSI. Placement competency frameworks and assessment tools define what students must demonstrate in community and hospital settings. |
| MPharm national learning outcomes (PSI-defined) | Structured data | The national learning outcome framework from which scenario objectives derive, enabling year-appropriate calibration. |
| PSI Professional Registration Examination (PRE) blueprint | Document chunks | The assessment framework for the final-year pre-registration examination. The highest-stakes assessment context for AccuRXy scenarios. |
| New pharmacy programmes: ATU Sligo, SETU Waterford, University of Galway (announced 2024) | Linked / referenced | Three new MPharm programmes designed to double Ireland's annual pharmacy graduate output. Documentation as it becomes available. |
Medication Safety: Error Taxonomy and Incident Learning
This is where AccuRXy's most distinctive intellectual property develops. The combination of a formal Irish-applicable error taxonomy with real Irish incident evidence produces scenarios that are both academically valid and clinically authentic. No generic AI tool can replicate this.
Irish incident evidence
| Source | Held as | Role in the evidence pack |
|---|---|---|
| PSI Learning from Inquiries (cross-referenced from Pillar 3) | Document chunks | Used here to extract error type, medicine class, dispensing stage, contributing factors and outcome, populating the AccuRXy proprietary error pattern library. |
| HPRA Drug Safety Newsletters (pharmacovigilance signals) | Document chunks | Safety signals that have reached regulatory action level in Ireland, providing evidence for plausible real-world consequences in scenarios. |
| State Claims Agency (SCA) Clinical Indemnity Scheme annual reports | Document chunks | Pharmacy and medicines-related claim patterns for Irish healthcare settings, showing the most clinically and financially consequential error types. |
Error classification and taxonomy
| Source | Held as | Role in the evidence pack |
|---|---|---|
| WHO Medication Without Harm, Global Patient Safety Challenge | Document chunks | The international WHO framework for medication safety, providing the overarching classification structure: patient factors, medication factors, healthcare provider factors and system factors. |
| ISMP error taxonomy | Structured data | The most widely used medication error classification system. Maps onto Irish practice and forms the basis for the AccuRXy proprietary error taxonomy. |
| NCC MERP index for categorising medication errors (categories A to I) | Structured data | The standard severity classification, from no-harm near miss through to patient death. Used in scenario metadata to tag difficulty and consequence level. |
| Dispensing error classifications | Structured data | AccuRXy proprietary taxonomy layer covering wrong patient, wrong drug, wrong dose, wrong strength, wrong formulation, wrong route, wrong frequency, wrong duration and wrong label. Each error type maps to scenario templates, clinical cues, common distractors, learner interventions and relevant legislation. |
Drug-specific safety materials
| Source | Held as | Role in the evidence pack |
|---|---|---|
| HPRA Educational Materials for high-risk medicines | Document chunks | Cross-referenced from Pillar 1. Define the specific dispensing interventions required for high-risk medicines and underpin high-stakes scenario design. |
| HSE warfarin anticoagulation information packs | Document chunks | HSE-produced patient information, the standard reference for anticoagulation monitoring scenarios, one of the highest-frequency dispensing error risks in Irish community pharmacy. |
| Joint Formulary Committee anticoagulation guidelines | Document chunks | Clinical context for warfarin dose adjustment, INR interpretation and patient counselling when INR is out of range. |
Linked and Referenced: External Sources
These sources are relevant to Irish pharmacy education but are not Irish-jurisdiction-specific, or require access or licensing arrangements AccuRXy does not yet hold. They are listed because pharmacy academics will reference them and scenario reviewers should understand where they sit in the source hierarchy.
| Source | Held as | Role in the evidence pack |
|---|---|---|
| EMC (Electronic Medicines Compendium) via Eolas Medical | Linked / referenced | UK SmPCs, live on the Eolas clinical platform. Relevant context where UK and Irish licences differ. Not the primary Irish source; medicines.ie and HPRA hold that role. |
| British National Formulary (BNF) and BNF for Children | Linked / referenced | Used contextually in Irish hospital settings even though not Ireland-specific. Acknowledged but never the primary evidence source in Irish scenarios. |
| EMA PRAC meeting highlights | Linked / referenced | EU-level safety signals that precede HPRA regulatory action, useful for advanced scenarios involving emerging safety concerns. |
| Cochrane Library systematic reviews | Linked / referenced | Evidence-based context behind therapeutic decisions, for scenarios that require justification of clinical choices in a specific patient profile. |
| Irish Pharmacy Journal (IPJ) | Document chunks | The official PSI publication: practice articles, research, professional guidance and continuing education content. |
| ISMP Medication Safety Alerts and High-Alert Medications list | Linked / referenced | Insulin, anticoagulants, concentrated electrolytes, chemotherapy and opioids. Internationally recognised and used in Irish hospital pharmacy. |
| WHO Essential Medicines List (Irish comparative context) | Linked / referenced | A reference framework for which medicines represent core therapeutic competence expectations, informing which drug classes the scenario library prioritises. |
08. Priority
The source hierarchy
When AccuRXy retrieves an evidence pack for an Irish scenario, it draws from the pillars in a defined priority order. Higher layers constrain what lower layers can produce.
Legislation
Pharmacy Act 2007, Misuse of Drugs Regulations 2017, Medicinal Products Regulations 2003
Regulatory authorisation
HPRA medicines database, medicines.ie SmPCs, EMA product information
Professional standards
PSI guidelines, PSI/Medical Council joint guidance, PSI Practice Updates
Competency framework
PSI Core Competency Framework, MPharm learning outcomes, PRE blueprint
Clinical medicines reference
Irish Medicines Formulary, NMIC bulletins, HSE MMP guidance
Incident learning
PSI Learning from Inquiries, HPRA Drug Safety Newsletters, SCA data
AccuRXy proprietary layer
Error taxonomy, scenario templates, difficulty calibration, distractor rules
When AccuRXy retrieves an evidence pack for an Irish scenario it draws from the pillars in this priority order. Higher layers constrain what lower layers can produce.
09. Review
Recommended next steps following academic review
Actions arising from review of the source inventory, spanning academic annotation, licensing, legal advice, data schema and partnerships.
Academic reviewers
Annotate gaps, corrections or additional sources expected for their institution's MPharm programme.
Commercial
Initiate the licensing conversation with IMF Media, the single most important source relationship for Irish jurisdiction accuracy.
Legal and compliance
Take advice on the use of PSI Learning from Inquiries cases in AI-generated educational scenarios, even though all are anonymised.
Development
Define the metadata schema for each source type (version, effective date, jurisdiction, document type, approval status) before ingestion begins.
Product
Map the source pillars to the Scenario Design Lab parameter set so each selection triggers the appropriate retrieval filters.
Partnerships
Explore a formal relationship with the PSI Education team, positioning AccuRXy as the national digital scenario platform ahead of the three new pharmacy school launches.
In plain language
AccuRXy uses a governed retrieval-augmented generation architecture. Approved academic, regulatory and medication-safety sources are stored in a version-controlled evidence platform and supplemented by structured medicines data and clinical validation rules. When a scenario is requested, AccuRXy retrieves a jurisdiction-appropriate evidence pack, instructs an approved language model to generate a structured scenario within that pack, validates the result, maps material claims to supporting source passages and submits the scenario for academic review.
The reference resources are not just accessible, they are central to every scenario from the first line of evidence retrieval through to the final audit record.
